Kolexia
Delaporte Eric
Médecine générale
Hôpital Gui de Chauliac
Montpellier, France
246 Activités
33 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Fièvre hémorragique à virus Ebola Maladies virales Entorses et foulures Zoonoses Syndrome d'immunodéficience acquise du singe COVID-19 Cryptococcose Co-infection

Industries

MSD
3 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

2020 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation.
The Lancet. Microbe   23 janvier 2024
Exploratory analysis of the knowledge, attitudes and perceptions of healthcare workers about arboviruses in the context of surveillance in the Republic of Guinea.
PLoS neglected tropical diseases   04 décembre 2023
Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study.
The Lancet. Infectious diseases   30 novembre 2023
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.
Open forum infectious diseases   20 novembre 2023
High Seroprevalence of IgG Antibodies to Multiple Arboviruses in People Living with HIV (PLWHIV) in Madagascar.
Viruses   15 novembre 2023
Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).
Journal of acquired immune deficiency syndromes (1999)   23 octobre 2023
EBO-SURSY project: multisectoral collaboration and research to build capacity for epidemiological surveillance of zoonoses in Africa.
Virologie (Montrouge, France)   21 septembre 2023
Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.
Frontiers in reproductive health   18 septembre 2023
Extensive Survey and Analysis of Factors Associated with Presence of Antibodies to Orthoebolaviruses in Bats from West and Central Africa.
Viruses   15 septembre 2023
Projet PREVAC-UP : la recherche clinique vaccinale contre Ebola comme levier de la coopération inter-universitaire et du renforcement des capacités en Guinée
Congrès International d’Épidémiologie et de Santé Publique « La Santé Publique face aux maladies émergentes et ré-émergentes » 2023   01 septembre 2023